Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

    High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

    FromJAMA Neurology Author Interviews

    Start listeningView podcast show

    High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

    FromJAMA Neurology Author Interviews

    ratings:
    Length:
    14 minutes
    Released:
    Mar 25, 2024
    Format:
    Podcast episode

    Description

    Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD. Related Content: High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
    Released:
    Mar 25, 2024
    Format:
    Podcast episode

    Titles in the series (100)

    Interviews with authors of articles from JAMA Neurology. JAMA Neurology is an international peer-reviewed journal for physicians caring for people with neurologic disorders and those interested in the structure and function of the normal and diseased nervous system.